Metabolic Drugs and Prostate Cancer: Analyzing GLP-1 Agonist Use in Patients - Amy Shaver June 22, 2025 Biographies: Amy Shaver, PhD, PharmD, MPH, Postdoctoral Research Fellow, Thomas Jefferson University, Philadelphia, PA Neeraj Agarwal, MD, FASCO, Professor, Presidential Endowed Chair of Cancer Research, Director GU Program and the Center of Investigational Therapeutics (CIT), Huntsman Cancer Institute, University of Utah, Salt Lake City, UT Read the Full Video Transcript Neeraj Agarwal: Hi
Retrieved from Unluhizarci, K., Karaca, Z., & Kelestimur, F
What is the SURMOUNT-5 trial
Improved Blood Sugar & Insulin Sensitivity Ideal for patients with insulin resistance, prediabetes, or metabolic syndrome
2023 [cited 2025 June 1]